ストックスクリーナーアプリを入手
1.67
0.24%
-0.00
前日終値:
$1.67
開ける：
$1.72
24時間の取引高:
22,792
Relative Volume:
0.15
時価総額：
$5.59M
収益：
$3.91M
当期純損益:
$-11.65M
株価収益率:
-0.1355
EPS:
-12.3212
ネットキャッシュフロー:
$-11.51M
1週間 パフォーマンス:
-2.57%
1か月 パフォーマンス:
-31.44%
6か月 パフォーマンス:
-46.60%
1年 パフォーマンス:
-83.98%
1日の値動き範囲:
$1.65
$1.75
1週間の範囲:
$1.60
$1.92
52週間の値動き範囲:
$1.52
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Compare INBS vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.685 | 5.64M | 3.91M | -11.65M | -11.51M | -12.32 |
ABT
Abbott Laboratories
|
97.45 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.46 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
273.41 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.24 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.08 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Intelligent Bio Solutions Inc (INBS) 最新ニュース
INBS: Innovative drug screening system targets U.S. entry with rapid, non-invasive testing and strong growth - TradingView
INBS: Innovative fingertip drug screening targets U.S. entry with FDA review and rapid expansion plans - TradingView
INTELLIGENT BIO SOLUTIONS INC. SEC Filing (Sep 24, 2026) - Stock Titan
Form 4 Intelligent Bio Solutions Inc For: 23 September By Investing.com - Investing.com UK
Intelligent Bio Solutions resolves all cybersecurity review items ahead of H2 2026 FDA filing - scanx.trade
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio (Nasdaq: INBS) may get up to $9.82M if resale-linked warrants are exercised - Stock Titan
Intelligent Bio (INBS) closes new private funding round - stocktitan.net
Intelligent Bio Solutions Shares Outstanding Reach 3,316,803 - minichart.com.sg
Form 8K Intelligent Bio Solutions Inc For: 11 September By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions updates outstanding shares count following warrant exercises - Investing.com
Intelligent Bio Solutions updates shares outstanding to 3,316,803 following warrant exercises - tradingview.com
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET - The Manila Times
A fingerprint drug test company will discuss its FDA submission Sept. 24 - stocktitan.net
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4: 30 p.m. ET - marketscreener.com
Intelligent Bio Solutions submits FDA application for codeine test By Investing.com - Investing.com South Africa
Intelligent Bio Solutions Files FDA 510(k) for U.S. Market Entry - Minichart
INBS Looks 7.4% Undervalued on GF Value™ Amid Challenging Price-to-Sales Dynamics - GuruFocus
Intelligent Bio Solutions submits FDA 510(k) for fingerprint drug screen after clinical studies show >98% accuracy - TradingView
Intelligent Bio Solutions submits FDA application for codeine test - Investing.com
Intelligent Bio Solutions Submits FDA 510(k) for Drug Screening System to Detect Codeine - Quiver Quantitative
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance - marketscreener.com
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market - Benzinga
A fingerprint drug test ruled out codeine in every negative sample. It was submitted to the FDA. - Stock Titan
Intelligent Bio Solutions Advances FDA Drug Screening Filing - TipRanks
Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Intelligent Bio Solutions Raises Up to $15M in Private Placement - minichart.com.sg
Intelligent Bio Solutions Completes $5 Million Private Placement - TipRanks
Intelligent Bio Solutions Raises $5 Million in Private Placement With Warrants - TradingView
INBS|Intelligent Bio Solutions Inc|Price:2.300|Chg%:-0.170 - TradingKey
Intelligent Bio Solutions Inc. announced that it has received $4.999998 million in funding - marketscreener.com
Intelligent Bio Solutions posts >98% accuracy in multi-site study, targets Sept 2026 510(k) - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Intelligent Bio Solutions Inc. announced that it expects to receive $4.999998 million in funding - marketscreener.com
INBS Stock Draws Traders As FDA 510(k) Milestones Pile Up - StocksToTrade
INBS Stock Steadies As FDA Milestones And Revenue Growth Stack Up - timothysykes.com
INBS Looks 3.4% Overvalued on GF Value™ - GuruFocus
Intelligent Bio Solutions reports improved drug screening accuracy - Investing.com India
Intelligent Bio Solutions reports improved drug screening accuracy By Investing.com - Investing.com Canada
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission - The Manila Times
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - The Manila Times
Intelligent Bio Solutions raises $5M in private placement By Investing.com - Investing.com Nigeria
A fingerprint drug test produced no false positives. Intelligent Bio Solutions expects an FDA filing in September. - Stock Titan
Press Release: Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - Moomoo
Intelligent Bio Solutions posts investor presentation on fingerprint sweat drug testing system - Bitget
Intelligent Bio Solutions(INBS) Stock Options Chain | Quotes & News - Moomoo
Intelligent Bio Solutions earnings missed by $4.88, revenue fell short of estimates - Investing.com Canada
Intelligent (INBS) Range: Posts a 1.31% Loss to $2.63 in the Latest Reading; Chart View: $2.50 and $2.76 Define the Nearby Reference Levels in the Current UpdateSize Factor - vinanet.vn
Intelligent Bio Solutions completes clinical data collection for FDA 510(k) - scanx.trade
INBS Looks 0.4% Overvalued on GF Value™ - GuruFocus
Intelligent Bio Solutions Revenue Rises 38% to $4.2 Million in Fiscal 2026 - Moomoo
Intelligent Bio Solutions Inc (INBS) 財務データ
収益
当期純利益
現金流量
EPS
0.99%
0.10%
大文字化:
|
ボリューム (24 時間):